Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation.
Ricci F, Balducci S, Guerrini F, Grassi S, Ciabatti E, Baratè C, Ferreri MI, Giuliani C, Valetto A, Petrini M, Galimberti S. Ricci F, et al. Among authors: balducci s. Clin Hematol Int. 2020 Jul 27;2(3):129-131. doi: 10.2991/chi.k.200714.001. eCollection 2020 Sep. Clin Hematol Int. 2020. PMID: 34595453 Free PMC article. No abstract available.
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.
Galimberti S, Petrini M, Baratè C, Ricci F, Balducci S, Grassi S, Guerrini F, Ciabatti E, Mechelli S, Di Paolo A, Baldini C, Baglietto L, Macera L, Spezia PG, Maggi F. Galimberti S, et al. Among authors: balducci s. Front Oncol. 2020 Sep 2;10:1428. doi: 10.3389/fonc.2020.01428. eCollection 2020. Front Oncol. 2020. PMID: 33014780 Free PMC article.
The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia.
Grassi S, Palumbo S, Mariotti V, Liberati D, Guerrini F, Ciabatti E, Salehzadeh S, Baratè C, Balducci S, Ricci F, Buda G, Iovino L, Mazziotta F, Ghio F, Ercolano G, Di Paolo A, Cecchettini A, Baldini C, Mattii L, Pellegrini S, Petrini M, Galimberti S. Grassi S, et al. Among authors: balducci s. Front Oncol. 2019 Jun 24;9:532. doi: 10.3389/fonc.2019.00532. eCollection 2019. Front Oncol. 2019. PMID: 31293972 Free PMC article.
The CoV-2 outbreak: how hematologists could help to fight Covid-19.
Galimberti S, Baldini C, Baratè C, Ricci F, Balducci S, Grassi S, Ferro F, Buda G, Benedetti E, Fazzi R, Baglietto L, Lucenteforte E, Di Paolo A, Petrini M. Galimberti S, et al. Among authors: balducci s. Pharmacol Res. 2020 Jul;157:104866. doi: 10.1016/j.phrs.2020.104866. Epub 2020 May 6. Pharmacol Res. 2020. PMID: 32387301 Free PMC article.
Myeloid neoplasms and autoimmune diseases: markers of association.
Galimberti S, Baldini C, Baratè C, Fornili M, Balducci S, Ricci F, Ferro F, Elefante E, Di Paolo A, Baglietto L, Donati V, Petrini M. Galimberti S, et al. Among authors: balducci s. Clin Exp Rheumatol. 2022 Jan;40(1):49-55. doi: 10.55563/clinexprheumatol/ddxmp9. Epub 2021 Jan 6. Clin Exp Rheumatol. 2022. PMID: 33427624 Free article.
Muscular Adaptations to Concurrent Resistance Training and High-Intensity Interval Training in Adults with Type 2 Diabetes: A Pilot Study.
Orlando G, Pugh J, Faulkner S, Balducci S, Sacchetti M, Pugliese G, Bazzucchi I, Haxhi J, Martinez-Valdes E, Falla D, Manolopoulos K, Nimmo MA. Orlando G, et al. Among authors: balducci s. Int J Environ Res Public Health. 2023 Sep 12;20(18):6746. doi: 10.3390/ijerph20186746. Int J Environ Res Public Health. 2023. PMID: 37754606 Free PMC article.
Sustained increase in physical fitness independently predicts improvements in cardiometabolic risk profile in type 2 diabetes.
Balducci S, Haxhi J, Vitale M, Mattia L, Sacchetti M, Orlando G, Cardelli P, Iacobini C, Bollanti L, Conti F, Zanuso S, Nicolucci A, Pugliese G; Italian Diabetes and Exercise Study 2 (IDES_2) Investigators. Balducci S, et al. Diabetes Metab Res Rev. 2023 Sep;39(6):e3671. doi: 10.1002/dmrr.3671. Epub 2023 Jun 14. Diabetes Metab Res Rev. 2023. PMID: 37312666 Clinical Trial.
A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients.
Severa M, Rizzo F, Sinigaglia A, Ricci D, Etna MP, Cola G, Landi D, Buscarinu MC, Valdarchi C, Ristori G, Riccetti S, Piubelli C, Palmerini P, Rosato A, Gobbi F, Balducci S, Marfia GA, Salvetti M, Barzon L, Coccia EM. Severa M, et al. Among authors: balducci s. Clin Transl Immunology. 2023 Mar 23;12(3):e1434. doi: 10.1002/cti2.1434. eCollection 2023. Clin Transl Immunology. 2023. PMID: 36969367 Free PMC article.
78 results